Number of the records: 1
rivastigmín
SYS d000068836 LBL 00000nz--a2200181n--4500 005 20250606221739.6 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.241.081.251.583.899 066 $a 01 $c 03 150 $a rivastigmín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a rivastigmín tartrát $2 slo 450 $w v $a rivastigmín hydrogén tartrát $2 slo 450 $w v $a ENA 713 $2 slo 550 $7 sllk_us_auth*d002800 $Y Cholinesterase Inhibitors $w P $a inhibítory cholínesteráz 550 $7 sllk_us_auth*d018696 $Y Neuroprotective Agents $w P $a látky neuroprotektívne 665 $a 2016 (1992) $2 eng 680 9-
$i A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE. $2 eng 750 -2
$a Rivastigmine $2 eng 980 $x M
Number of the records: 1